Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study
Andrés Yarur(Cedars-Sinai Medical Center), Brian Bressler(University of British Columbia), Erin Cook(Analysis Group (United States)), Gautam Sajeev(Analysis Group (United States)), Shashi Adsul(Takeda (United States)), Song Wang(University of Jinan), Pravin Kamble(Takeda (United States)), Annie Guérin(Group for Research in Decision Analysis), Gerassimos J. Mantzaris(European CanCer Organisation)
Cited by 5
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478